| Market cap | Sales (TTM) | Net profit (TTM) | P/E | EPS (TTM) | P/B | ROE | ROCE | Debt / equity | Free cash flow | EV / EBITDA | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹363 cr | ₹378 cr | ₹16 cr | 22.4 | 7.33 | 2.22 | 9.9% | 9.9% | 0.56 | ₹35 cr | 9.7 | 0.25 |
| Quarter | Sales ₹ cr | Net profit ₹ cr | EPS | EPS YoY | Sales YoY | Net margin |
|---|---|---|---|---|---|---|
| Sep 2026 | 95 | 6 | 2.58 | -55.6% | +88.1% | 5.9% |
| Jun 2026 | 101 | 5 | 2.32 | +21.5% | +51.4% | 5.1% |
| Mar 2026 | 104 | 2 | 0.89 | -55.3% | +22.5% | 1.9% |
| Dec 2025 | 77 | 3 | 1.54 | — | — | 4.2% |
| Sep 2025 | 51 | 4 | 5.81 | — | — | 7.1% |
| Jun 2025 | 67 | 4 | 1.91 | — | — | 6.3% |
| Mar 2025 | 85 | 2 | 1.99 | — | — | 2.5% |
| Check | Result |
|---|---|
| Latest quarter EPS up 25%+ on a year ago | ✗ Fail |
| EPS growth positive and accelerating over 3 consecutive quarters | ✗ Fail |
| Sales up 25%+, or sales growth positive and accelerating | ✓ Pass |
| Annual EPS up 25%+ in each of the last 2 years (3 full years needed) | — Not assessable |
| Net margin above the same quarter last year | ✗ Fail |
| Quarter | Promoters | FIIs | DIIs | Retail & others | Promoter shares pledged |
|---|---|---|---|---|---|
| Sep 2026 | 52.50% | 0.30% | 0.00% | 47.20% | 0.00% |
| Jun 2026 | 52.50% | 0.11% | 0.00% | 47.39% | 0.00% |
| Mar 2026 | 52.50% | 0.11% | 0.00% | 47.39% | 0.00% |
| Dec 2025 | 52.50% | 0.11% | 0.00% | 47.39% | 0.00% |
| Sep 2025 | 52.50% | 0.11% | 0.00% | 47.39% | 0.00% |
| Jun 2025 | 52.50% | 0.11% | 0.00% | 47.39% | 0.00% |
| Apr 2025 | 52.50% | 0.11% | 0.00% | 47.39% | 0.00% |
| Mar 2025 | 67.78% | 0.15% | 0.00% | 32.07% | 0.00% |
| Method | Checks | Score | Verdict |
|---|---|---|---|
| Minervini | ✗ Close above the 150- and 200-day averages ✗ 150-day above 200-day ✗ 200-day rising for a month ✗ 50-day above the 150- and 200-day ✗ Close above the 50-day ✗ At least 25% above the 52-week low · low 160.36 ✗ Within 25% of the 52-week high · high 438.25 ✗ RS percentile 70 or more · RS 2 Minervini's trend template - the gate the scanner applies. | 0/8 | 0 of 8 |
| Weinstein | Stan Weinstein's stage analysis on the 30-week moving average. | Stage 4 - declining | |
| CAN SLIM | ✗ C latest quarter EPS up 25%+, with sales up 25%+ or accelerating — A annual EPS up 25%+ in each of the last 2 years · O'Neil asks 3; ~2 held ✗ N (proxy) near the 52-week high - within 15% · high 438.25 ✗ S (proxy) more volume on up days than down days (50 sessions) · 0.20x ✗ L RS percentile 80 or more · RS 2 ✗ I (proxy) FII + DII holding trend · 0.3% - too little institutional ownership to count ✓ M (proxy) market in an uptrend, 40%+ of stocks above their 200-day - shared, not counted · breadth 49% William O'Neil's growth-leader checklist, as a checklist score: the six stock letters counted equally, though O'Neil read them together. M is the market condition, shown but not counted. N, S, I and M are proxies. | 0/5 | Weak |
| Darvas | ✗ New 52-week high in the last 120 sessions Darvas needs a new 52-week high to start a box. | 10/100 | No box |
| Turtle | ✗ Close above the prior 55-session high · 223.45 ✗ Close above the prior 20-session high · 182.00 ✗ Close below the prior 20-session low (also a Turtle exit level) · 150.00 Turtle-inspired long breakout: the Turtle traders' entry channels only - no exits, stops or position sizing. | No signal | |
| Greenblatt | — Earnings yield (EBIT / enterprise value) · 7.0% — Return on capital (filed ROCE - adapted) · 9.9% Joel Greenblatt's Magic Formula, adapted: a relative ranking among non-financial, non-utility companies above Rs 500 crore. Return on capital uses filed ROCE, not Greenblatt's tangible-capital measure. Strong = top 30% of that ranking, not a test passed. | 39/100 | Weak |
| Graham | ✗ Price at or below the Graham number · Graham number 110.37 · price / Graham number 1.49 · trailing 4-quarter EPS (3 years not held) ✗ P/E 15 or less · P/E 22.4 on trailing 4-quarter EPS (3 years not held) ✗ P/B 1.5 or less (or P/E x P/B 22.5 or less) · P/B 2.22 · P/E x P/B 49.7 ✓ Current ratio 2 or more · 3.34 ✓ Long-term debt no more than net current assets · debt 611,062,000 · net current assets 841,731,000 — Positive earnings in every full year held — 20 years of dividends, 10-year earnings growth, adequate size · not assessed Graham number valuation: the price against sqrt(22.5 x EPS x book value per share). Graham's defensive tests are listed separately; this is not his full defensive screen. | Above Graham number | |
| Piotroski | ✓ Profitable (ROA > 0, on beginning-of-year assets) ✓ Operating cash flow positive — ROA rising · needs three years ✓ Cash flow above net profit (earnings quality) — Long-term debt / average assets lower · needs three years ✓ Current ratio higher · 1.88 ✗ No new equity issued · share capital x1.33, bonus/split x1.00 — Gross margin higher · not assessed - gross profit not filed here — Asset turnover higher (sales / beginning assets) · needs three years Piotroski F-score (adapted), FY 2025 -> 2026: 4 of 9 passed, 4 not assessed. Piotroski applied it to value stocks; here it is shown for all non-financial companies. | 4/9 | Average |
| Stock | 1M % | 3M % | 6M % | 1Y % | 3Y % | 5Y % | P/E | P/B | ROE % | ROCE % | ROA % | D/E | EV/EBITDA | ₹ Cr | Sales TTM ₹ Cr | Profit TTM ₹ Cr | EPS | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABCIND this stock | -14.3 | -22.3 | -25.0 | -60.8 | — | — | 22.4 | 2.22 | 9.9 | 9.9 | 4.33 | 0.56 | 9.7 | 363 | 378 | 16 | 7.3 | 0.25 |
| SCPL | +5.3 | -5.2 | +40.8 | +183.8 | +87.2 | — | 29.8 | 3.99 | 13.4 | — | — | 0.57 | 15.9 | 667 | 395 | 22 | 21.3 | 0.43 |
| PREMIERPOL | -21.9 | -7.0 | +48.2 | +85.9 | +155.1 | +481.0 | 23.5 | 5.23 | 24.1 | 32.9 | 17.42 | 0.00 | 18.0 | 877 | 396 | 37 | 3.5 | 0.55 |
| CALSOFT | -22.4 | -4.7 | +19.5 | +58.0 | +91.4 | -17.3 | 10.5 | 3.87 | 32.3 | 42.0 | 27.61 | 0.12 | 1.1 | 16 | 26 | 15 | 2.5 | 0.55 |
| DIGJAMLMTD | +34.2 | +37.0 | +47.3 | +55.2 | -19.8 | +42.4 | 68.4 | 20.28 | -20.3 | 5.2 | -1.28 | 9.10 | 42.6 | 134 | 33 | 2 | 1.0 | 0.93 |
| VALIANTLAB | +0.6 | +107.2 | +61.7 | +52.1 | -37.7 | — | 42.7 | 2.20 | -1.2 | 0.8 | -0.76 | 0.14 | 84.8 | 683 | 306 | 16 | 3.0 | 0.80 |
| CHEMBONDCH | +5.5 | -15.9 | +26.6 | +47.4 | — | — | 18.7 | 2.94 | 15.8 | — | — | 0.01 | 12.2 | 638 | 370 | 34 | 12.7 | 1.34 |
| NILKAMAL | +22.1 | +2.9 | +69.0 | +42.5 | -5.0 | -9.2 | 19.8 | 1.91 | 7.5 | 10.0 | 4.59 | 0.16 | 10.3 | 3,138 | 3,873 | 159 | 106.5 | 0.69 |
| AKSHARCHEM | -16.0 | +15.4 | +78.2 | +40.0 | +38.7 | -22.4 | 9.7 | 0.97 | -0.2 | 0.7 | -0.10 | 0.36 | 7.4 | 280 | 488 | 29 | 35.8 | 0.71 |
| 21STCENMGM | +67.7 | +55.6 | +74.2 | +36.0 | +253.1 | +10.7 | — | 1.14 | 33.3 | 36.8 | 28.65 | 0.00 | 3.2 | 67 | — | — | — | 0.31 |
| MARALOVER | +3.6 | +7.2 | +31.5 | +29.6 | -15.9 | -23.3 | — | 2.21 | — | — | — | — | — | — | — | — | — | 1.02 |
← All NSE stocks · More Other stocks